Cargando…
CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1- induced T cell acute lymphoblastic leukemia
T-cell acute lymphoblastic leukemia (T-ALL) is a high-risk subset of acute leukemia, characterized by frequent activation of Notch1 or AKT signaling, where new_therapeutic approaches are needed. We showed previously that Cyclin-dependent kinase 6 (CDK6) is required for thymic lymphoblastic lymphoma...
Autores principales: | Jena, Nilamani, Sheng, Jinghao, Hu, Jamie K., Li, Wei, Zhou, Wenhui, Lee, Gene, Tsichlis, Nicolaos, Pathak, Aparna, Brown, Nelson, Deshpande, Amit, Luo, Chi, Hu, Guo-fu, Hinds, Philip W., Van Etten, Richard A., Hu, Miaofen G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856559/ https://www.ncbi.nlm.nih.gov/pubmed/26707936 http://dx.doi.org/10.1038/leu.2015.353 |
Ejemplares similares
-
CDK6 inhibits white to beige fat transition by suppressing RUNX1
por: Hou, Xiaoli, et al.
Publicado: (2018) -
Ikaros mutation confers integrin-dependent pre-B cell survival and progression to acute lymphoblastic leukemia
por: Joshi, Ila, et al.
Publicado: (2014) -
CDK6 is essential for mesenchymal stem cell proliferation and adipocyte differentiation
por: Hu, Alexander J., et al.
Publicado: (2023) -
Proteasome inhibitors exert cytotoxicity and increase chemosensitivity via transcriptional repression of Notch1 in T-cell acute lymphoblastic leukemia
por: Koyama, D, et al.
Publicado: (2014) -
Rational drug combinations with CDK4/6 inhibitors in acute lymphoblastic leukemia
por: Bride, Karen L., et al.
Publicado: (2021)